Phlow Partners With USP On Continuous Manufacturing

Alliance To Validate Production Processes Could Be ‘Catalyst For Industry Change’

Phlow Corp has announced a strategic alliance with the US Pharmacopeia to certify and validate continuous manufacturing processes as it aims to bolster US supplies of essential medicines. The company believes the move could serve as a catalyst for wider generics industry adoption of continuous manufacturing.

Continuous Production Manufacturing Gears
Phlow has struck a strategic alliance with USP on continuous manufacturing • Source: Shutterstock

Phlow Corp has announced a strategic alliance with the US Pharmacopeia to develop a laboratory that will certify and validate its continuous manufacturing processes, as the US government-funded company seeks to bolster the domestic supply of essential medicines. 

Phlow – which was last year awarded hundreds of millions of dollars in US government funding, as part of a...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business